Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Can stimulant rebound mimic pediatric bipolar disorder?

Sarampote CS, Efron LA, Robb AS, Pearl PL, Stein MA.

J Child Adolesc Psychopharmacol. 2002 Spring;12(1):63-7.

PMID:
12014597
2.

Inattentive Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Weight Loss in a 15-Year-Old Girl: Are We Enabling the Development of an Eating Disorder?

Iyer S, Kumar M, Reiff MI, Stein MT.

J Dev Behav Pediatr. 2015 Sep;36(7):549-51. doi: 10.1097/DBP.0000000000000202.

PMID:
26348973
3.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
4.

Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset.

DelBello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM.

Bipolar Disord. 2001 Apr;3(2):53-7.

PMID:
11333062
7.
8.
9.

ADHD (ATTENTION DEFFICIT HYPERACTIVITY DISORDER)--A TROUBLING ENTITY, SOMETIMES PERPETUATING DURING ADULT LIFE.

Amihăesei IC, Zamfir CL.

Rev Med Chir Soc Med Nat Iasi. 2016 Jan-Mar;120(1):10-4.

PMID:
27125066
10.

The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities.

Newcorn JH, Weiss M, Stein MA.

CNS Spectr. 2007 Aug;12(8 Suppl 12):1-14; quiz 15-6.

PMID:
17667893
11.

Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication.

Brossard-Racine M, Shevell M, Snider L, Bélanger SA, Majnemer A.

Res Dev Disabil. 2012 Nov-Dec;33(6):2080-7. doi: 10.1016/j.ridd.2012.06.003. Epub 2012 Jul 13.

PMID:
22796639
12.

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

Faraone SV, Glatt SJ.

J Clin Psychiatry. 2010 Jun;71(6):754-63. doi: 10.4088/JCP.08m04902pur. Epub 2009 Dec 29.

PMID:
20051220
13.

Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.

Kummer A, Teixeira A.

Australas Psychiatry. 2008 Dec;16(6):458-9. No abstract available.

PMID:
19034996
15.

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.

Ross RG.

Am J Psychiatry. 2006 Jul;163(7):1149-52. No abstract available.

PMID:
16816217
16.

Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.

Biederman J, Seidman LJ, Petty CR, Fried R, Doyle AE, Cohen DR, Kenealy DC, Faraone SV.

J Clin Psychiatry. 2008 Jul;69(7):1150-6.

17.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
18.

Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder.

Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, Hartman CA, Luman M, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV.

Br J Psychiatry. 2013 Aug;203(2):112-9. doi: 10.1192/bjp.bp.112.124784. Epub 2013 Jul 11. Erratum in: Br J Psychiatry. 2014 Jun;204(6):494.

19.
20.

Attention deficit hyperactivity disorder, CNS stimulants and sport.

Hickey G, Fricker P.

Sports Med. 1999 Jan;27(1):11-21. Review.

PMID:
10028130

Supplemental Content

Support Center